Godoy Junior, Carlos Antonio http://orcid.org/0009-0008-0871-459X
Miele, Francesco http://orcid.org/0000-0003-1337-9112
Mäkitie, Laura http://orcid.org/0000-0002-4063-6674
Fiorenzato, Eleonora http://orcid.org/0000-0001-7947-5903
Koivu, Maija http://orcid.org/0000-0002-7921-5412
Bakker, Lytske Jantien http://orcid.org/0000-0001-8583-0115
Groot, Carin Uyl-de http://orcid.org/0000-0001-5808-302X
Redekop, William Ken http://orcid.org/0000-0001-9538-4083
van Deen, Welmoed Kirsten http://orcid.org/0000-0002-4836-9849
Funding for this research was provided by:
H2020 European Research Council (101016902)
Article History
Accepted: 10 December 2023
First Online: 5 January 2024
Declarations
:
: This research is part of the AICCELERATE project. This project has received funding from the European Union’s Horizon 2020 research and innovation program under Grant agreement no. 101016902.
: Carlos Antonio Godoy Junior—No conflicts of interests to disclose. Francesco Miele—No conflicts of interests to disclose. Laura Mäkitie—Received personal fees from Abbvie outside the submitted work. Maija Koivu—No conflicts of interest to disclose. Eleonora Fiorenzato—No conflicts of interests to disclose. Lytske Jantien Bakker—No conflicts of interests to disclose. Carin Uyl-de Groot—No conflicts of interests to disclose. William Ken Redekop—No conflicts of interests to disclose. Welmoed Kirsten van Deen—No conflicts of interests to disclose.
: The data underlying this article cannot be shared publicly to protect the privacy of individuals that participated in the study.
: The study was conducted according to the principles of the Declaration of Helsinki and in accordance with the Medical Research Involving Human Subjects Act (WMO) and was approved by the local ethics committees at HUS (HUS/2349/2021), UNIPD (2020-III/13.41.7) and Erasmus University Rotterdam (ETH2122-0569). An informed consent was obtained from all interviewees before participation.